J3370 Vancomycin HCl 500mg | HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS J3370: Vancomycin HCl 500 mg Injection

HCPCS Level II code J3370 denotes a 500 mg injection of vancomycin hydrochloride, a key intravenous antibiotic for serious gram-positive infections. This code matters nationally because vancomycin is commonly used for severe infections, including methicillin-resistant Staphylococcus aureus (MRSA), and contributes significantly to inpatient and outpatient infusion service volumes and drug spend.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for vancomycin use, typical sites of service where billed doses occur, and the payer landscape relevant to reimbursement and claim processing. The publication outlines billing benchmarks, common modifier usage patterns, and coding considerations relevant to facilities and office-based infusion practices. Policy and coverage notes summarize Medicare and major commercial payer priorities that influence prior authorization, medical necessity review, and payment policies for injectable antimicrobials.

The content is intended to inform billing professionals, revenue cycle managers, clinicians involved in infusion services, and policymakers about how HCPCS Level II code J3370 is used in practice, what payers prioritize in coverage and claims review, and where stakeholders may encounter coding and documentation issues.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ3370HCPCS Level IIvancomycininjectioninfusionantimicrobial therapydrug codinghospital outpatientphysician office

Billing Code Overview

HCPCS Level II code J3370 represents an injection of vancomycin hydrochloride, 500 mg. The service is an antibiotic infusion/injection used for treatment of serious gram-positive bacterial infections, often administered intravenously.

Service Type: Injection / Antimicrobial Therapy

Typical Site of Service: Hospital inpatient, hospital outpatient, infusion center, or physician office

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult hospitalized for suspected or confirmed Gram-positive serious infection (for example, methicillin-resistant Staphylococcus aureus bacteremia, complicated skin and soft tissue infection, or prosthetic joint infection) requiring intravenous antibiotic therapy. The treating team (hospitalist or infectious disease physician) orders J3370 for vancomycin 500 mg. Nursing or an infusion pharmacist prepares the dose, often diluting vancomycin for intravenous infusion and administering via peripheral or central venous access in the inpatient setting, emergency department, or outpatient infusion center. Baseline and interval labs (renal function, vancomycin trough or area-under-curve monitoring) and vital sign monitoring occur per facility protocol. Documentation includes indication, dose and concentration, route, start and stop times, patient tolerance, and any adverse reactions. Typical sites of service are inpatient acute care, hospital outpatient department, emergency department, and ambulatory infusion centers.

Coding Specifications

Modifier	Description	When to Use
`11`	Primary procedure	When `J3370` is the primary service performed during the encounter.

Related Codes

HCPCS-J1306-INCLISIRAN-INJECTION-1MG

HCPCS J1306: Inclisiran Injection, 1 mg

HCPCS-J7614-LEVALBUTEROL-INHALATION-SOLUTION-0-5MG-UNIT-DOSE

HCPCS Level II J7614: Levalbuterol Inhalation Solution, 0.5 mg Unit Dose

HCPCS-J2267-MIRIKIZUMAB-INJECTION-1MG

HCPCS J2267: Injection, mirikizumab-mrkz, 1 mg

HCPCS-J0613-CALCIUM-GLUCONATE-INJECTION-CRITICAL-CARE-10MG

HCPCS J0613: Calcium Gluconate Injection, Critical Care 10 mg

HCPCS-J3387-ELIVALDOGENE-AUTOTEMCEL-GENE-THERAPY-INJECTION

HCPCS J3387: Injection, elivaldogene autotemcel, per treatment

HCPCS-J3374-VANCOMYCIN-HYDROCHLORIDE-MYLAN-10MG-INJECTION

HCPCS J3374: Vancomycin Hydrochloride (Mylan) Injection, 10 mg

HCPCS-J0879-DIFELIKEFALIN-INJECTION-ESRD-DIALYSIS

HCPCS J0879: Injection of difelikefalin for ESRD on Dialysis

HCPCS-J0616-METOPROLOL-TARTRATE-INJECTION-1MG

HCPCS J0616: Injection, Metoprolol Tartrate, 1 mg

HCPCS-J1439-FERRIC-CARBOXYMALTOSE-INJECTION-1MG

HCPCS J1439: Ferric Carboxymaltose Injection, 1 mg

HCPCS-J1952-LEUPROLIDE-CAMCEVI-INJECTABLE-1MG

HCPCS Level II J1952: Leuprolide injectable (camcevi), 1 mg

Showing 1–10 of 991

Taxonomy Code	Specialty	Notes
`207Q00000X`	Infectious Disease	Common ordering and oversight specialty for IV vancomycin therapy.
`207RH0000X`	Hospitalist/Internal Medicine	Frequently manages inpatient antibiotic administration and monitoring.
`163W00000X`	Critical Care Medicine	Manages vancomycin in critically ill patients in ICU settings.
`363A00000X`	Emergency Medicine	Initiates empiric IV vancomycin in emergency department prior to admission or discharge with infusion.
`261QM1300X`	Nurse Practitioner	Performs and documents administration in ambulatory infusion settings or inpatient care.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`A41.9`	Sepsis, unspecified organism	Vancomycin used empirically for suspected Gram-positive sepsis including MRSA coverage.
`J15.211`	Pneumonia due to methicillin-resistant Staphylococcus aureus	Vancomycin is an accepted treatment for MRSA pneumonia.
`M86.9`	Osteomyelitis, unspecified	Used for bone infections where IV vancomycin is indicated for MRSA or other resistant Gram-positive pathogens.
`T82.7XXA`	Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter	Vancomycin used for prosthetic device–related infections.
`L03.90`	Cellulitis, unspecified	For severe or complicated skin and soft tissue infections where IV therapy is required.
`B96.0`	Staphylococcus aureus as the cause of diseases classified elsewhere	Indicates S. aureus infection where targeted therapy with vancomycin may be indicated.
`G06.0`	Intracranial abscess and granuloma	Serious deep-seated infections where IV vancomycin may be part of multimodal therapy.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96365`	Intravenous infusion, initial, for therapy, prophylaxis, or diagnosis; up to 1 hour	Used when vancomycin infusion is billed as an infusion service (initial hour) in outpatient or office-based infusion settings.
`96366`	Intravenous infusion, each additional hour	Used when the infusion extends beyond the initial hour for prolonged administration or monitoring.
`96374`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug	Used when vancomycin is administered as an IV push (rare due to infusion-related reactions) and documentation supports push technique.
`36415`	Collection of venous blood by venipuncture	Used for lab monitoring such as vancomycin trough or renal function tests associated with therapy.
`99223`	Initial hospital care, typically 70 minutes or more	Represents physician evaluation and management for hospitalized patients initiating IV vancomycin therapy; used where applicable to capture clinical management.